331 related articles for article (PubMed ID: 35260290)
1. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
[TBL] [Abstract][Full Text] [Related]
2. Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis.
Jin Y; Ma X; Yang Z; Zhang N
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):697-705. PubMed ID: 36720459
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
Huang CY; Sun FJ; Lee J
Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis.
Ubachs J; Ziemons J; Minis-Rutten IJG; Kruitwagen RFPM; Kleijnen J; Lambrechts S; Olde Damink SWM; Rensen SS; Van Gorp T
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1165-1174. PubMed ID: 31389674
[TBL] [Abstract][Full Text] [Related]
5. Association between CT-based body composition assessment and patient outcomes during neoadjuvant chemotherapy for epithelial ovarian cancer.
Wood N; Morton M; Shah SN; Yao M; Barnard H; Tewari S; Suresh A; Kollikonda S; AlHilli MM
Gynecol Oncol; 2023 Feb; 169():55-63. PubMed ID: 36508759
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis.
Rinninella E; Fagotti A; Cintoni M; Raoul P; Scaletta G; Scambia G; Gasbarrini A; Mele MC
Int J Gynecol Cancer; 2020 May; 30(5):654-663. PubMed ID: 32241875
[TBL] [Abstract][Full Text] [Related]
7. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Sarcopenia and Low Muscle Attenuation on Overall Survival in Epithelial Ovarian Cancer: A Systematic Review and Meta-analysis.
McSharry V; Mullee A; McCann L; Rogers AC; McKiernan M; Brennan DJ
Ann Surg Oncol; 2020 Sep; 27(9):3553-3564. PubMed ID: 32221737
[TBL] [Abstract][Full Text] [Related]
9. Muscle composition measured by CT scan is a measurable predictor of overall survival in advanced ovarian cancer.
Kumar A; Moynagh MR; Multinu F; Cliby WA; McGree ME; Weaver AL; Young PM; Bakkum-Gamez JN; Langstraat CL; Dowdy SC; Jatoi A; Mariani A
Gynecol Oncol; 2016 Aug; 142(2):311-6. PubMed ID: 27235857
[TBL] [Abstract][Full Text] [Related]
10. The impact of body composition on treatment in ovarian cancer: a current insight.
McSharry V; Glennon K; Mullee A; Brennan D
Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1065-1074. PubMed ID: 34080491
[TBL] [Abstract][Full Text] [Related]
11. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.
van der Zanden V; van Soolingen NJ; Viddeleer AR; Trum JW; Amant F; Mourits MJE; Portielje JEA; van den Bos F; de Kroon CD; Kagie MJ; Oei SA; Baalbergen A; van Haaften-de Jong ALD; Houtsma D; van Munster BC; Souwer ETD
Gynecol Oncol; 2021 Aug; 162(2):360-367. PubMed ID: 34112514
[TBL] [Abstract][Full Text] [Related]
12. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of sarcopenia in patients with rectal cancer: A meta-analysis.
Zhu Y; Guo X; Zhang Q; Yang Y
PLoS One; 2022; 17(6):e0270332. PubMed ID: 35749415
[TBL] [Abstract][Full Text] [Related]
14. Value of sarcopenia assessed by computed tomography for the prediction of postoperative morbidity following oncological colorectal resection: A comparison with the malnutrition screening tool.
van der Kroft G; Bours DMJL; Janssen-Heijnen DM; van Berlo DCLH; Konsten DJLM
Clin Nutr ESPEN; 2018 Apr; 24():114-119. PubMed ID: 29576348
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia in Advanced Serous Ovarian Cancer.
Bronger H; Hederich P; Hapfelmeier A; Metz S; Noël PB; Kiechle M; Schmalfeldt B
Int J Gynecol Cancer; 2017 Feb; 27(2):223-232. PubMed ID: 27870708
[TBL] [Abstract][Full Text] [Related]
16. Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Ovarian Cancer Treated With Primary Surgery Followed by Platinum-based Chemotherapy: A Single-center Italian Study.
Gadducci A; Simonetti E; Mezzapesa F; Cosio S; Miccoli M; Frey J; Tintori R; Bulleri A; Neri E
Anticancer Res; 2022 Feb; 42(2):947-954. PubMed ID: 35093894
[TBL] [Abstract][Full Text] [Related]
17. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
[TBL] [Abstract][Full Text] [Related]
18. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis.
Xia W; Barazanchi AWH; MacFater WS; Hill AG
Injury; 2019 Sep; 50(9):1565-1576. PubMed ID: 31280971
[TBL] [Abstract][Full Text] [Related]
19. Computed Tomography-Assessed Sarcopenia Indexes Predict Major Complications following Surgery for Hepatopancreatobiliary Malignancy: A Meta-Analysis.
Cao Q; Xiong Y; Zhong Z; Ye Q
Ann Nutr Metab; 2019; 74(1):24-34. PubMed ID: 30513518
[TBL] [Abstract][Full Text] [Related]
20. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
